Liberati A, Altman DG, Tetzlaff J, Mulrow C, Gtzsche PC, Ioannidis JPA, et al
This observational analysis is the first to compare combination therapy of newer generation GLP-1RAs (including dual GLP-1/GIP agonists) and SGLT2is with SGLT2is alone and provides reassurance that the combination is likely more effective for improving cardiorenal and metabolic outcomes in people with T2D
Take a look at our menus to see delicious choices for breakfast, lunch, and dinner fully prepared and ready to eat
A pharmacogenetic study of escitalopram in autism spectrum disorders
How PlexusDx Supports a More Personalized Approach PlexusDx's Precision Peptide Genetic Test may help provide context for your appetite phenotype and GLP-1 pathway sensitivity by examining predispositions in GLP1R, GIPR, FTO, and MC4R variants